1. PKC signaling in cancer.A.P. Fields (Jacksonville, FL, USA)-(Oct. 6)

2. Hepatocellular carcinoma.Keichi Kubota (Mibu, Tochigi, Japan)-(Oct. 8)

3. Cancer Prevention in Asia Pacific Countries.C.H. Yip (Petaling Jaya, Malaysia), C.J. Chen (Taipei, Taiwan) (APOCP)-(Oct. 9)

4. Invasion and carcinomas of the GI tract.O.D. Laerum (Bergen, Norway)-(Oct. 8)

5. Toxicology and cancer aetiology.C.H. Yip (Petaling Jaya, Malaysia), C.J. Chen (Taipei, Taiwan) (APOCP)-(Oct. 9)

6. Genomic instability and cancer (DNA repair).A. Wani (Columbus, OH, USA)-(Oct. 6)

7. Drug resistance in cancer and targeting DNA repair pathways.S. Mitra (Galveston, TX, USA)-(Oct. 8)

8. Image-guided radiotherapy.Nam Nguyen (Tucson, AZ, USA)-(Oct. 7)

9. Circulating tumor cells.M. Rigaud (Limoges, France)-(Oct. 6)

10. Cancer stem cells.M. Jhanwar-Uniyal (New York, NY, USA), F. Guadagni (Rome, Italy)-(Oct. 7)

11. Regulation of efflux pumps of mdr cancer by phenothiazine derivatives and natural products.L. Amaral (Lisbon, Portugal), J. Molnar (Szeged, Hungary)- (Oct. 10)

12. Drug delivery.D. Vetvicka (Prague, Czech Republic)-(Oct. 6)

13. Genomics and clinical management of ovarian cancer.R. Ganapathi (Charlotte, NC, USA)-(Oct. 6)

14. New insights in prostate cancer.C. Aukim-Hastie (Guildford, Surrey, UK)- (Oct. 6)

15. Hox genes in cancer.C. Aukim-Hastie (Guildford, Surrey, UK)-(Oct. 7)

16. Application of RT-qPCR in Biomedicine.F.E. Ahmed (Greenville, NC, USA)-(Oct. 7)

17. Vitamin D and Cancer.M. Friedrich (Krefeld, Germany), J. Reichrath (Homburg/Saar, Germany)- (Oct. 8)

18. Biobanks: A research infrastructure for the future of translational and clinical research.F. Guadagni, M. Roselli, F. Betsou (Rome, Italy)- (Oct. 8) / Under the auspices of ISBER

19. New insight into brain tumors.G. Sica (Rome, Italy), M. Jhanwar-Uniyal (New York, NY, USA)-(Oct. 10)

20. Micro RNAs in cancer.A. Seth (Toronto, ON, Canada)-(Oct. 10)

1 2



The role of atypical PKC1 in cancer stem cell maintenance and tumor formation.A.P. FieldsJacksonville, FLUSA

Antigen-specific T cells responses to breast cancer.J. SlanskyDenver, COUSA

Systematic subsegmentectomy for patients with hepatocellular carcinoma.K. KubotaMibu, TochigiJapan

Prediction of postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma.K. KubotaMibu, TochigiJapan

Five MicroRNA Signature for Prostate Cancer Recurrence and Metastasis.A. SethToronto, ONCanada

Role of IGFBP7 in Breast Cancer.A. SethToronto, ONCanada

In Vivo Imaging of Antitumor Lymphocytes.D. CharaciejusVilniusLithuania

Family of Peptides Synthesized in the Human Body Have Anticancer Effects.D.L. VeselyTampa, FLUSA

BAC analysis of chromosomal translocation breakpoints: an efficient strategy for identifying new candidate genes in malignant hemopathies.M. De BraekeleerBrestFrance

Identification of PRRC1-MLL, a novel fusion gene, in a case of therapy-related acute lymphoblastic leukemia.M. De BraekeleerBrestFrance

Glycoproteomics Strategies in Cancer Biomarker Discovery.O.J. SemmesNorfolk, VAUSA

Macrophages expressing the receptor of urokinase plasminogen activator (uPAR) are key players of invasiveness and poor prognosis in adenocarcinomas of the gastrointestinal tract.O.D. LaerumBergenNorway

Epigenetics of the 162/H19 locus.W. EngströmUppsalaSweden

Modeling molecular signaling of endocrine resistance in breast cancer.R. ClarkeWashington, DCUSA

ROS/RNS in multistep oncogenesis.G. BauerFreiburgGermany

Novel therapeutic approaches based on specific ROS signalling.G. BauerFreiburgGermany

Magnetic nanoparticles for innovative cancer therapy.C. AlexiouErlangenGermany

Colon cancer diagnosis by microRNAs.F.E. AhmedGreenville, NCUSA

Introduction to efflux pumps of mdr cancer and methods used for their evaluation.L. AmaralLisbonPortugal

Prognostic tumor markers for breast cancer.V. BarakJerusalemIsrael

1 2 3 46